In the present study we aimed to characterize the effects of QBECO treatment on gastrointestinal pathology using two different experimental models of colitis, the commonly used DSS model of chemical-induced colitis and the spontaneous colitis that develops in Muc2 deficient (Muc2−/−) mice. This evidence concerns the gene MUC2 and colitis.